In this issue:
Screening for the ALK gene
A predictive model for estimating EGFR mutation
Microwave ablation of earlystage NSCLC
Lung cancer screening websites
Malignant pleural effusion: talc poudrage vs intercostal drainage
Durvalumab consolidation in real-world practice
Carboplatin-pemetrexed first-line for elderly NSCLC patients?
KEYNOTE studies of pembrolizumab:
- combination therapy for SCLC (KEYNOTE-604)
- combination therapy for NSCLC (KEYNOTE-189)
- monotherapy for PD-L1–positive NSCLC (KEYNOTE-010)
Please login below to download this issue (PDF)